You are here

  • Home
  • Archive
  • Volume 88, Issue 5
  • A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial

Citation Tools

Article menu
Download PDFPDF
Poster Abstracts
Abstracts
63
A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Dodick D, Ashina M, Kudrow D, et al
A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial
Journal of Neurology, Neurosurgery & Psychiatry 2017;88:e1.